Le Lézard
Classified in: Health
Subjects: NPT, TDS, HSP, WOM, BLK, FVT

Women of Color in Pharma Marks Official Launch with First Annual Conference

SOMERSET, N.J., Oct. 5, 2017 /PRNewswire/ -- Women of Color in Pharma (WOCIP) today announced that its official launch will take place at the WOCIP first annual conference, scheduled for Sunday, November 5 and Monday, November 6, 2017 in Princeton, N.J. WOCIP is a professional society focused on fostering the growth and development of Black and Latina women in the pharmaceutical industry. WOCIP enables the cultivation of a sustainable pipeline of Black and Latina women leaders who, together, can harness the power of their diverse expertise, bringing a competitive advantage to industry.

"WOCIP's vision is to enable the transformation of the pharmaceutical professional landscape with women of color," said co-founder Charlotte Jones-Burton, M.D., M.S. "Our mission is to empower women of color in pharma to excel in their personal and professional development and to transform their pathway within the pharmaceutical industry."

Speakers at the first annual conference include representatives from pharmaceutical companies and contract research organizations. Wanda Bryant Hope, Chief Diversity Officer for Johnson & Johnson, will deliver the keynote address. Other speakers include Michelle Amador of Covance, Marisa Co of Bristol-Myers Squibb, Cristina Santos of Sanofi, and Celeste Warren of Merck. The conference is co-sponsored by Bristol-Myers Squibb and Novo Nordisk, with generous support from Covance.

"The conference theme is 'Get Inspired. Be Empowered,'" said co-founder Patricia Cornet, M.A. "We welcome colleagues in the pharmaceutical industry who are interested in engaging in professional development, networking and discussing key areas that are shaping the pharmaceutical landscape for WOCIP to join us."  

The Conference opens with a welcome reception on Sunday, November 5 at 6 p.m. at the Hyatt Regency in Princeton, N.J. The full-day conference is Monday, November 6 at 8 a.m. at the Novo Nordisk Inc. training facility in Princeton, N.J. To register, visit the WOCIP website http://wocip.org/conferences/

About Women of Color in Pharma (WOCIP)

Women of Color in Pharma (WOCIP) is a 501(c) (6) non-profit corporation whose purpose is to promote the development and advancement of women of color who are employed in the pharmaceutical industry. Founded in March 2015 by Charlotte Jones-Burton, M.D., M.S. and Patricia Cornet, M.A., WOCIP has an informal network of approximately 500 members and is supported by member dues and corporate sponsors. For more information, please visit http://wocip.org/.

Jill Vitiello
Vitiello Communications Group
O: 732-238-6622 ext. 501
M: 908-420-3506

SOURCE Women of Color in Pharma

These press releases may also interest you

at 13:00
Eli Lilly Canada Inc. (Lilly) is pleased to announce the Health Canada approval and availability of ENTUZITYtm KwikPen® (insulin human biosynthetic 500 units/mL) for the treatment of adults and children with diabetes requiring insulin. ENTUZITY is...

at 13:00
Vitalah®, the Proud Creators of Oxylent® (www.oxylent.com), have partnered with Whole Planet Foundation during the month of December to help alleviate poverty throughout the world. Founded in 2005, Whole Planet Foundation is a Whole Foods Market...

at 13:00
Gateway Rehab's independent correctional division Community Transitions Centers (CTC) announced that it would maintain its operations at Braddock and Erie, Pa., which were previously reported to be closing.  Following recent developments in the...

at 12:42
Midtown Wellness, is pleased to announce they now offer GAINSWavetm! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction symptoms....

at 12:41
Highlighting its nationally recognized achievements in patient safety and quality, Capital Health Regional Medical Center was named a Top General Hospital by The Leapfrog Group, making it the only New Jersey hospital to earn this distinction....

at 12:41
For large hospitals and healthcare employers, specialty drugs are the single largest driver of the alarming increases in healthcare costs.  To help employers grappling with soaring costs, Strategic Benefit Advisors (SBA) has released a white paper...

News published on 5 october 2017 at 11:45 and distributed by: